Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
Xing Huang, Tianyu Tang, Gang Zhang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 83
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 70
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
Xing Huang, Gang Zhang, Tianyu Tang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 63
Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
Tao Huang, Lushan Peng, Yingying Han, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors
Jianghua Wang, Xiaoting Li, Guanxi Xiao, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 7
Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
Hua Zhong, Shuai Liu, Fang Cao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
A review on the advances and challenges of immunotherapy for head and neck cancer
Gang Cheng, Hui Dong, Chen Yang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 40
Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
Lin Han, Kun Wang, Yuxin Xiong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
Changwu Wu, Chaoying Qin, Wenyong Long, et al.
Journal Of Big Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Precision Medicine in Biliary Tract Cancer
Aaron J. Scott, Reya Sharman, Rachna T. Shroff
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2716-2734
Closed Access | Times Cited: 27
mRNA Vaccine - A New Cancer Treatment Strategy
Tian Tan, Shuting Deng, Bing-Huo Wu, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 9, pp. 669-681
Closed Access | Times Cited: 16
A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma
Lu Chen, Guotao Yin, Ziyang Wang, et al.
BioScience Trends (2024) Vol. 18, Iss. 3, pp. 263-276
Open Access | Times Cited: 5
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
Linghong Huang, Xin‐Yuan Sun, Qinhua Zuo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101523-101523
Open Access
Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development
Ronghua Yang, Jia He, Deni Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
Rafieh Bagherifar, Seyed Hossein Kiaie, Zahra Hatami, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 33
Cancer immunotherapy strategies that target the cGAS-STING pathway
Zhuoying Tian, Yue Zeng, Yurong Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Xianzhe Yu, Lingling Zhu, Ting Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
New systemic treatment options for advanced cholangiocarcinoma
Valentina Zanuso, Giulia Tesini, Elena Valenzi, et al.
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 155-170
Open Access | Times Cited: 4
The progress of tumor vaccines clinical trials in non-small cell lung cancer
Xiaomu Wang, Yunping Niu, 芳久 渡辺
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 4
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers
Ruyin Chen, Dandan Zheng, Qiong Li, et al.
Cancer Letters (2022) Vol. 546, pp. 215853-215853
Closed Access | Times Cited: 21
Advances in immunotherapy for biliary tract cancers
Yuhao Zhao, Mao Yang, Jiayi Feng, et al.
Chinese Medical Journal (2023) Vol. 137, Iss. 5, pp. 524-532
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top